Mostrando ítems 1-2 de 2
Giró Perafita, Ariadna (Fecha de defensa: 2017-01-17)
Triple-negative breast cancer (TNBC) represents 20% of breast cancer and patients receive only general chemotherapy. The epidermal growth factor receptor (EGFR) is commonly expressed in TNBC and it is ...
Polonio Alcalá, Emma (Fecha de defensa: 2023-05-17)
Although there are therapies for triple negative breast cancer (TNBC) and epidermal growth factor-mutated non-small cell lung cancer (EGFRm NSCLC), these two subtypes of cancer are very aggressive, and ...